Skip to main content
SpringerLink
Log in

5 Handlungsempfehlungen für die Praxis

Antipsychotische Delir-Therapie: Immer auf die QTc-Zeit achten!

Antipsychotic pharmacotherapy for delirious syndrome — only temporary, symptom- oriented and considering QTc time (short version)

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die medikamentöse Behandlung deliranter Syndrome erfolgt überwiegend mit Antipsychotika. Diese können zu einer QTc-Zeit-Verlängerung führen. Praktische Tipps für den Umgang mit dieser Therapie gibt der nachfolgende Beitrag.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Burry L, Mehta S, Perreault MM et al. Antipsychotics for treatment of delirium in hospitalised non-ICU patients. The Cochrane database of systematic reviews 2018; 6: Cd005594

    PubMed  Google Scholar 

  2. Fontaine GV, Mortensen W, Guinto KM et al. Newly Initiated In-Hospital Antipsychotics Continued at Discharge in Non-psychiatric Patients. Hospital pharmacy 2018; 53: 308–315

    Article  Google Scholar 

  3. Kim DH, Mahesri M, Bateman BT et al. Longitudinal Trends and Variation in Antipsychotic Use in Older Adults After Cardiac Surgery. Journal of the American Geriatrics Society 2018; 66: 1491–1498

    Article  Google Scholar 

  4. Wenzel-Seifert K, Wittmann M, Haen E. Psychopharmakoassoziierte QTc-Intervall-Verlängerung und Torsade de Pointes. Deutsches Arzteblatt international 2011; 108: 687–693

    PubMed  PubMed Central  Google Scholar 

  5. Bohlken J, Hewer W, Kostev K. Inzidenz und Behandlung des nicht stoffgebundenen Delirs in deutschen Haus- und Facharztpraxen Fortschritte der Neurologie-Psychiatrie 2018; 86: 616–623

    Google Scholar 

  6. Ng KT, Shubash CJ, Chong JS. The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis. Anaesthesia 2018, DOI: https://doi.org/10.1111/anae.14472

    Article  Google Scholar 

  7. Dube KM, DeGrado J, Hohlfelder B et al. Evaluation of the Effects of Quetiapine on QTc Prolongation in Critically Ill Patients. Journal of pharmacy practice 2018; 31: 292–297

    Article  Google Scholar 

  8. Tomaselli Muensterman E, Tisdale JE. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review. Pharmacotherapy 2018; 38: 813–821

    Article  Google Scholar 

  9. Haverkamp W, Deuschle M. Antipsychotikainduzierte QT-Verlängerung. Der Nervenarzt 2006; 77: 276, 278-280, 282-274 passim

    Article  CAS  Google Scholar 

  10. Aronow WS, Shamliyan TA. Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders. Annals of translational medicine 2018; 6: 147

    Article  CAS  Google Scholar 

  11. Meyer-Massetti C, Cheng CM, Sharpe BA et al. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? Journal of hospital medicine 2010; 5: E8–16

    Article  Google Scholar 

  12. Brouillette J, Nattel S. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications. The Canadian journal of cardiology 2017; 33: 1577–1586

    Article  Google Scholar 

  13. Vandael E, Vandenberk B, Vandenberghe J et al. A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model. British journal of clinical pharmacology 2018; 84: 2824–2835

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum rechts der Isar, Klinik für Psychiatrie und Psychotherapie, Schlafmedizinisches Zentrum, Ismaninger Straße 22, D-81675, München, Deutschland

    Dirk Schwerthöffer,  Johannes Förstl &  Bastian Fatke

Authors
  1. Dirk Schwerthöffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Förstl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bastian Fatke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirk Schwerthöffer.

Additional information

Zusatzmaterial online

Zu diesem Beitrag ist unter www.springermedizin.de/mmw Zusatzmaterial abrufbar: — Abb. 1: Algorithmus für die Antipsychotikatherapie des Delirs unter Beachtung der QTc-Zeit

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwerthöffer, D., Förstl, J. & Fatke, B. Antipsychotische Delir-Therapie: Immer auf die QTc-Zeit achten!. MMW - Fortschritte der Medizin 161, 50–52 (2019). https://doi.org/10.1007/s15006-019-1009-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-019-1009-3

Keywords

Search

Navigation